97 related articles for article (PubMed ID: 7237469)
1. Radiometric enzyme-inhibition technique for measuring acivicin in plasma.
Jayaram HN; Kensler TW; Ardalan B
Cancer Treat Rep; 1981; 65(5-6):491-4. PubMed ID: 7237469
[TBL] [Abstract][Full Text] [Related]
2. An enzymatic technique for measuring N-phosphonacetyl-L-aspartic acid in tissues.
Cooney DA; Karlowicz MG; Cubillan J; Roettger M; Jayaram HN
Cancer Treat Rep; 1978 Oct; 62(10):1503-7. PubMed ID: 361225
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of resistance of a variant of P388 leukemia to L-(alpha S,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (acivicin).
Jayaram HN; Ardalan B; Deas M; Johnson RK
Cancer Res; 1985 Jan; 45(1):207-12. PubMed ID: 2578092
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of antitumor activity of glutamine antagonists 6-diazo-5-oxo-L-norleucine and acivicin in cell culture by glutaminase-asparaginase.
Rosenfeld H; Roberts J
Cancer Res; 1981 Apr; 41(4):1324-8. PubMed ID: 7214322
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic and biochemical studies on acivicin in phase I clinical trials.
McGovren JP; Pratt EA; Belt RJ; Taylor SA; Benjamin RS; Ardalan B; Ohnuma T
Cancer Res; 1985 Sep; 45(9):4460-3. PubMed ID: 3896481
[TBL] [Abstract][Full Text] [Related]
6. Rapid in vivo inactivation by acivicin of CTP synthetase, carbamoyl-phosphate synthetase II, and amidophosphoribosyltransferase in hepatoma.
Denton JE; Lui MS; Aoki T; Sebolt J; Weber G
Life Sci; 1982 Mar; 30(13):1073-80. PubMed ID: 7078346
[TBL] [Abstract][Full Text] [Related]
7. Effects of acivicin and PALA, singly and in combination, on de novo pyrimidine biosynthesis.
Kensler TW; Jayaram HN; Cooney DA
Adv Enzyme Regul; 1982; 20():57-73. PubMed ID: 7113804
[TBL] [Abstract][Full Text] [Related]
8. In vivo inactivation by acivicin of carbamoyl-phosphate synthetase II in rat hepatoma.
Aoki T; Sebolt J; Weber G
Biochem Pharmacol; 1982 Mar; 31(6):927-32. PubMed ID: 7082374
[TBL] [Abstract][Full Text] [Related]
9. Inactivation by acivicin of carbamoyl-phosphate synthetase II of human colon carcinoma.
Sebolt JS; Aoki T; Eble JN; Glover JL; Weber G
Biochem Pharmacol; 1985 Jan; 34(1):97-100. PubMed ID: 3966920
[TBL] [Abstract][Full Text] [Related]
10. Acivicin inhibits Crithidia fasciculata growth in a serum-free medium and inactivates carbamoyl-phosphate synthetase II in vivo.
Aoki T; Oya H
Comp Biochem Physiol C Comp Pharmacol Toxicol; 1988; 90(2):391-6. PubMed ID: 2902999
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of Crithidia fasciculata carbamoyl phosphate synthetase II by the antitumor drug acivicin.
Aoki T; Oya H
Mol Biochem Parasitol; 1987 Mar; 23(2):173-81. PubMed ID: 3574357
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effects of acivicin and N-(phosphonacetyl)-L-aspartic acid in a biochemically designed trial against a N-(phosphonacetyl)-L-aspartic acid-resistant variant of the Lewis lung carcinoma.
Kensler TW; Reck LJ; Cooney DA
Cancer Res; 1981 Mar; 41(3):905-9. PubMed ID: 7459876
[No Abstract] [Full Text] [Related]
13. Carbamyl phosphate synthetase III, an evolutionary intermediate in the transition between glutamine-dependent and ammonia-dependent carbamyl phosphate synthetases.
Hong J; Salo WL; Lusty CJ; Anderson PM
J Mol Biol; 1994 Oct; 243(1):131-40. PubMed ID: 7932737
[TBL] [Abstract][Full Text] [Related]
14. The glutamine analog acivicin as antipyrimidine. Studies on the interrelationship between pyrimidine and urea synthesis in liver.
Pausch J; Rasenack J; Häussinger D; Holstege A; Gerok W
Adv Enzyme Regul; 1985; 24():233-43. PubMed ID: 3835821
[TBL] [Abstract][Full Text] [Related]
15. Role of the hinge loop linking the N- and C-terminal domains of the amidotransferase subunit of carbamoyl phosphate synthetase.
Huang X; Raushel FM
Arch Biochem Biophys; 2000 Aug; 380(1):174-80. PubMed ID: 10900147
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of cell cycle progression of human pancreatic carcinoma cells in vitro by L-(alpha S, 5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid, Acivicin (NSC 163501).
Meck RA; Clubb KJ; Allen LM; Yunis AA
Cancer Res; 1981 Nov; 41(11 Pt 1):4547-53. PubMed ID: 7306976
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effects with inhibitors of de novo pyrimidine synthesis, acivicin, and N-(phosphonacetyl)-L-aspartic acid.
Loh E; Kufe DW
Cancer Res; 1981 Sep; 41(9 Pt 1):3419-23. PubMed ID: 7260907
[TBL] [Abstract][Full Text] [Related]
18. Biochemical pharmacology of acivicin in rat hepatoma cells.
Lui MS; Kizaki H; Weber G
Biochem Pharmacol; 1982 Nov; 31(21):3469-73. PubMed ID: 7150366
[TBL] [Abstract][Full Text] [Related]
19. Acivicin. An antitumor antibiotic.
Poster DS; Bruno S; Penta J; Neil GL; McGovren JP
Cancer Clin Trials; 1981; 4(3):327-30. PubMed ID: 7026076
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of the amidotransferase activity of carbamoyl phosphate synthetase by the antibiotic acivicin.
Miles BW; Thoden JB; Holden HM; Raushel FM
J Biol Chem; 2002 Feb; 277(6):4368-73. PubMed ID: 11729189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
